These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31309714)

  • 21. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
    Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    Lo Re V; Dutcher SK; Connolly JG; Perez-Vilar S; Carbonari DM; DeFor TA; Djibo DA; Harrington LB; Hou L; Hennessy S; Hubbard RA; Kempner ME; Kuntz JL; McMahill-Walraven CN; Mosley J; Pawloski PA; Petrone AB; Pishko AM; Driscoll MR; Steiner CA; Zhou Y; Cocoros NM
    JAMA; 2022 Aug; 328(7):637-651. PubMed ID: 35972486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.
    Sørensen HT; Horvath-Puho E; Pedersen L; Baron JA; Prandoni P
    Lancet; 2007 Nov; 370(9601):1773-9. PubMed ID: 18037081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
    Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers D; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
    Thromb Res; 2020 Jul; 191():148-150. PubMed ID: 32381264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of Venous Thromboembolism Risk to Ischemic Stroke Risk in Hospitalized Patients with Cancer.
    Corley AM; Sullivan MJ; Friedman SE; O'Rourke DJ; Palac RT; Gemignani AS
    Am J Cardiol; 2019 Feb; 123(4):679-683. PubMed ID: 30528279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematocrit and incidence of venous thromboembolism.
    Folsom AR; Wang W; Parikh R; Lutsey PL; Beckman JD; Cushman M;
    Res Pract Thromb Haemost; 2020 Mar; 4(3):422-428. PubMed ID: 32211576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.
    Liang RA; Høiland II; Ueland T; Aukrust P; Snir O; Hindberg K; Braekkan SK; Garred P; Mollnes TE; Hansen JB
    J Thromb Haemost; 2019 Oct; 17(10):1661-1669. PubMed ID: 31220397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematocrit and risk of venous thromboembolism in a general population. The Tromso study.
    Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
    Haematologica; 2010 Feb; 95(2):270-5. PubMed ID: 19833630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke.
    Sundbøll J; Darvalics B; Horváth-Puhó E; Adelborg K; Laugesen K; Schmidt M; Henderson VW; Sørensen HT
    J Thromb Haemost; 2018 Nov; 16(11):2175-2183. PubMed ID: 30179297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet count and the risk for thrombosis and death in the elderly.
    van der Bom JG; Heckbert SR; Lumley T; Holmes CE; Cushman M; Folsom AR; Rosendaal FR; Psaty BM
    J Thromb Haemost; 2009 Mar; 7(3):399-405. PubMed ID: 19143922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
    Lodigiani C; Iapichino G; Carenzo L; Cecconi M; Ferrazzi P; Sebastian T; Kucher N; Studt JD; Sacco C; Bertuzzi A; Sandri MT; Barco S;
    Thromb Res; 2020 Jul; 191():9-14. PubMed ID: 32353746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis.
    Sørensen HT; Horvath-Puho E; Lash TL; Christiansen CF; Pesavento R; Pedersen L; Baron JA; Prandoni P
    Circulation; 2011 Sep; 124(13):1435-41. PubMed ID: 21900083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism.
    Takach Lapner S; Julian JA; Linkins LA; Bates S; Kearon C
    Thromb Haemost; 2017 Oct; 117(10):1937-1943. PubMed ID: 28771280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
    Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers DAMPJ; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
    Thromb Res; 2020 Jul; 191():145-147. PubMed ID: 32291094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study.
    Donzé JD; Ridker PM; Finlayson SR; Bates DW
    BMJ; 2014 Sep; 349():g5334. PubMed ID: 25199629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism.
    Brenner B; Bikdeli B; Tzoran I; Madridano O; López-Reyes R; Suriñach JM; Blanco-Molina Á; Tufano A; Núñez JJL; Trujillo-Santos J; Monreal M;
    Am J Med; 2018 Sep; 131(9):1095-1103. PubMed ID: 29807000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study.
    Nørgaard I; Nielsen SF; Nordestgaard BG
    Clin Chem; 2016 Mar; 62(3):525-34. PubMed ID: 26797686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.